Assyro AI

Orange Book product · Brand (NDA)

CEDAX

CEFTIBUTEN DIHYDRATE

Brand (NDA)NDA 050685DISCN BURKE THERAP

At a glance

Dec 20, 1995

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 20, 1995

    30 yr 11 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CEFTIBUTEN DIHYDRATE

Strength

EQ 400MG BASE

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

NDA 050685

Product number

002

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.